[Treatment of diabetic retinopathy and recurrent hemorrhages into the vitreous with calcium dobesilate].
D000328:Adult; D000368:Aged; D002196:Capillaries / Q000187:drug effects; D002200:Capillary Resistance / Q000187:drug effects; D002908:Chronic Disease; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy*; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D008266:Macula Lutea; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012166:Retinal Hemorrhage / Q000188:drug therapy; D014792:Visual Acuity / Q000187:drug effects; D014822:Vitreous Body
D006490:Hemostatics
Le traitement de la rétinopathie diabétique et de l'hémorragie récidivante du vitré par le dobésilate de calcium.